Loma Therapeutics ApS
Private limited companyCVR 44226189København NActive
Loma Therapeutics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2023. Equity was negative at the end of 2025 (−DKK 8.1m). The company made a loss in both 2024 and 2025, most recently DKK 3.5m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 4.6m to DKK 3.5m (2024 → 2025).
Employees
- 1 more employees than a year earlier: 6 (07/2026) against 5 (07/2025).
Management and owners, last 24 months
- New in management: Alejandra Maria Cristina Bonifacini Mørk (chair of the board, 13/01/2025), Leif Helth Jensen (board member, 13/01/2025) and Stuart John Myles Collinson (board member, 13/01/2025) (+1).
- New owners registered: Northgaard Holding ApS (13/01/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | −2,143 | −483 | +77.5% |
| Operating profit (EBIT) | −4,298 | −3,543 | +17.6% |
| Profit before tax | −4,622 | −4,089 | +11.5% |
| Net profit | −4,622 | −3,540 | +23.4% |
| Total assets | 5,113 | 7,338 | +43.5% |
| Equity | −4,582 | −8,122 | −77.3% |
| Liabilities | 9,694 | 15,460 | +59.5% |
| Cash and cash equivalents | 5,041 | 7,199 | +42.8% |
| Average number of employees | 5 | 5 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 8.1m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 27/05/2026 | The company | PDF not statedXBRL |
| 2024 | 09/08/2023 – 31/12/2024 | 05/06/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,033of 69,742 Better than 2% | No. 69,498of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 219of 323 Better than 32% | No. 304of 329 Better than 8% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,103of 16,614 Better than 3% | No. 16,576of 16,661 Better than 1% |
| All companies of type ApS66,508 companies in the comparison | No. 65,049of 66,379 Better than 2% | No. 66,043of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Loma Therapeutics ApS−DKK 483k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Loma Therapeutics ApS−DKK 3.5m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Loma Therapeutics ApS−DKK 8.1m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Loma Therapeutics ApS6
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Ditte Boilesen Holding ApS33.33%
- Holstein-Rønsbo Holding ApS33.33%
- Northgaard Holding ApS5%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Ditte Rahbæk Boilesen | Director | 09/08/2023 |
| Stephanie Holstein-Rønsbo | Director | 09/08/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Alejandra Maria Cristina Bonifacini Mørk | Chair of the board | 13/01/2025 |
| Leif Helth Jensen | Board member | 13/01/2025 |
| Stuart John Myles Collinson | Board member | 13/01/2025 |
| Ralf Wagner | Board member | 13/01/2025 |
- Founders
- Peter Holst Consulting ApS, Ditte Boilesen Holding ApS, Holstein-Rønsbo Holding ApS, WFLAG Holding GmbH, Christian Thirion
Signing rule: Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Loma Therapeutics ApS | Ole Maaløes Vej 3, 2200 København N | 6 | 1029537115 |
Purpose
Selskabets formål er at foretage forskning, udvikling og kommercialisering inden for medicinske produkter.
The purpose is quoted from the register in Danish.
Changes year by year
13 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20257 changesaccounts 1 · management 4 · ownership 1 · industry 1
- AccountsAnnual report for 2024 published
- ManagementAlejandra Maria Cristina Bonifacini Mørk appointed chair of the board
- ManagementLeif Helth Jensen appointed board member
- ManagementStuart John Myles Collinson appointed board member
- ManagementRalf Wagner appointed board member
- OwnershipNorthgaard Holding ApS registered as owner (5%)
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20235 changesfounded 1 · management 2 · ownership 2
- FoundedRegistered as Loma Therapeutics ApS
- ManagementDitte Rahbæk Boilesen appointed director
- ManagementStephanie Holstein-Rønsbo appointed director
- OwnershipDitte Boilesen Holding ApS registered as owner (33.33%)
- OwnershipHolstein-Rønsbo Holding ApS registered as owner (33.33%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Genmab A/Svia Leif Helth Jensen
- Zealand Pharma A/Svia Leif Helth Jensen
- Phillips-Medisize A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Klifo A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Takeda Pharma A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Glycom A/Svia Leif Helth Jensen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.